Ro7200220 for Diabetic MacUlar Edema
Research payments
$761,277
Through program year 2021, $761,277 in research payments was reported against Ro7200220 for Diabetic MacUlar Edema, across 85 payments, paid by Roche TCRC, Inc..
- Paid by
- Roche TCRC, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $20,716 | 1 |
| 2020 | Research | $616,723 | 67 |
| 2019 | Research | $123,838 | 17 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Brian Berger Austin, TX Named on 13 payments
- Vrinda Hershberger Melbourne, FL Named on 12 payments
- David Eichenbaum Saint Petersburg, FL Named on 12 payments
- Michael Samuel Pasadena, CA Named on 11 payments
- Victor Gonzalez McAllen, TX Named on 6 payments
- Firas Rahhal Los Angeles, CA Named on 6 payments
- Arshad Khanani Reno, NV Named on 6 payments
- Michael Singer San Antonio, TX Named on 4 payments
- Quan Nguyen Palo Alto, CA Named on 3 payments
- Sunil Patel Abilene, TX Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.